Ortho-Clinical expects to redeem 7 3/8%, 7¼% notes due 2025, 2028

By Wendy Van Sickle

Columbus, Ohio, May 19 – Ortho-Clinical Diagnostics, Inc. and Ortho-Clinical Diagnostics Sarl expect to issue conditional notices to fully redeem their outstanding 7 3/8% senior notes due 2025 and 7¼% senior notes due 2028 on June 1, according to an 8-K filing with the Securities and Exchange Commission.

The planned redemptions are in connection with the expected combination of Ortho Clinical Diagnostics Holdings plc and subsidiaries with Quidel Corp. and conditioned upon consummation of that combination. The redemptions may be postponed if the combination is delayed.

The issuer is a Raritan, N.J.-based in vitro diagnostics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.